LIXT
Price
$4.11
Change
-$0.18 (-4.20%)
Updated
Jul 25 closing price
Capitalization
12.44M
PTHS
Price
$21.99
Change
-$0.01 (-0.05%)
Updated
Jul 25 closing price
Capitalization
14.26M
38 days until earnings call
Interact to see
Advertisement

LIXT vs PTHS

Header iconLIXT vs PTHS Comparison
Open Charts LIXT vs PTHSBanner chart's image
Lixte Biotechnology Holdings
Price$4.11
Change-$0.18 (-4.20%)
Volume$147.75K
Capitalization12.44M
Pelthos Therapeutics
Price$21.99
Change-$0.01 (-0.05%)
Volume$10.16K
Capitalization14.26M
LIXT vs PTHS Comparison Chart in %
Loading...
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIXT vs. PTHS commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIXT is a StrongBuy and PTHS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (LIXT: $4.11 vs. PTHS: $21.99)
Brand notoriety: LIXT and PTHS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIXT: 5% vs. PTHS: 13%
Market capitalization -- LIXT: $12.44M vs. PTHS: $14.26M
LIXT [@Biotechnology] is valued at $12.44M. PTHS’s [@Biotechnology] market capitalization is $14.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIXT’s FA Score shows that 0 FA rating(s) are green whilePTHS’s FA Score has 0 green FA rating(s).

  • LIXT’s FA Score: 0 green, 5 red.
  • PTHS’s FA Score: 0 green, 5 red.
According to our system of comparison, LIXT is a better buy in the long-term than PTHS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIXT’s TA Score shows that 7 TA indicator(s) are bullish while PTHS’s TA Score has 5 bullish TA indicator(s).

  • LIXT’s TA Score: 7 bullish, 4 bearish.
  • PTHS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LIXT is a better buy in the short-term than PTHS.

Price Growth

LIXT (@Biotechnology) experienced а +1.23% price change this week, while PTHS (@Biotechnology) price change was +8.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

PTHS is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS($14.3M) has a higher market cap than LIXT($12.4M). PTHS YTD gains are higher at: 243.058 vs. LIXT (102.493). LIXT has more cash in the bank: 1.39M vs. PTHS (131K). LIXT has less debt than PTHS: LIXT (100K) vs PTHS (2.5M).
LIXTPTHSLIXT / PTHS
Capitalization12.4M14.3M87%
EBITDA-3.31MN/A-
Gain YTD102.493243.05842%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash1.39M131K1,057%
Total Debt100K2.5M4%
FUNDAMENTALS RATINGS
LIXT: Fundamental Ratings
LIXT
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LIXTPTHS
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RYI22.650.22
+0.98%
RYERSON HOLDING Corp
APAM46.650.15
+0.32%
Artisan Partners Asset Management
TLK17.35-0.05
-0.29%
PT Telekomunikasi Indonesia
ULBI8.62-0.13
-1.49%
Ultralife Corp
CANF0.98-0.03
-2.97%
Can-Fite BioPharma Ltd

LIXT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIXT has been loosely correlated with LIANY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIXT jumps, then LIANY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
-4.20%
LIANY - LIXT
34%
Loosely correlated
+18.26%
PTHS - LIXT
34%
Loosely correlated
-0.05%
ABOS - LIXT
29%
Poorly correlated
N/A
NTLA - LIXT
28%
Poorly correlated
+6.38%
IBIO - LIXT
28%
Poorly correlated
-0.88%
More

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been closely correlated with SONN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTHS jumps, then SONN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-0.05%
SONN - PTHS
70%
Closely correlated
-5.45%
KLRS - PTHS
39%
Loosely correlated
-2.82%
LIXT - PTHS
34%
Loosely correlated
-4.20%
CGTX - PTHS
31%
Poorly correlated
-2.51%
MBIO - PTHS
29%
Poorly correlated
-5.91%
More